Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists - X-MOL
Carlos SILVESTRE-ROIG | PostDoc Position | PhD | Ludwig-Maximilians-University of Munich, Munich | LMU
PDF) Neutrophilic granulocytes - promiscuous accelerators of atherosclerosis
Structure-based peptide design targeting intrinsically disordered proteins: Novel histone H4 and H2A peptidic inhibitors - ScienceDirect
Atherosclerosis: Treatment and Prevention - 1st Edition - Christian W
Oliver Soehnlein received two prestigious awards - SFB 914 Trafficking of Immune Cells in Inflammation, Development and Disease - LMU Munich
Soehnlein| CiM-IMPRS Graduate Program Münster
CV Oliver Weber
Einfluss der inneren Uhr bei Atherosklerose: DZHK
Arterial Delivery of VEGF-C Stabilizes Atherosclerotic Lesions | Circulation Research
Oliver Soehnlein received two prestigious awards - SFB 914 Trafficking of Immune Cells in Inflammation, Development and Disease - LMU Munich
Soehnlein in der Personensuche von Das Telefonbuch
Soehnlein| CiM-IMPRS Graduate Program Münster
Oliver Soehnlein: H-index & Awards - Academic Profile | Research.com
Figure 2 from Multiple Roles for Neutrophils in Atherosclerosis Oliver Soehnlein | Semantic Scholar
Oliver Soehnlein – MD, PhD – RWTH Aachen | LinkedIn
Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases | Cellular & Molecular Immunology
PDF) Intravital imaging of phagocyte recruitment
Interview with Dr Oliver Söhnlein, winner of the Outstanding Achievement Award 2017
Oliver Soehnlein Institute for Cardiovascular Prevention (IPEK), Klinikum der Universität München, Ludwig-Maximilians-University, Germany —BIO-PROTOCOL
Univ.-Prof. Dr. Dr. med. Oliver Söhnlein: DZHK
Oliver Soehnlein: H-index & Awards - Academic Profile | Research.com
